The AMSBIO range contains over 23,000 polyclonal & monoclonal antibodies, peptides, recombinant proteins, extracellular matrix, molecular detection reagents, & tissue DNA, RNA, proteins & microarray products. Key study areas consist of: apoptosis, cell invasion & migration, cell signaling, DNA damage, 3D lifestyle, electrophoresis, glycobiology, post-translational modification & stem cell biology.. AMSBIO expands its range of cell adhesion assays AMSBIO has expanded it is range of products for cell behaviour and growth with a suite of Cell Adhesion Assays, designed to evaluate optimal cell attachment to extracellular matrices and assess factors that impact cell-matrix interactions. Cell adhesion assays measure adhesion between cells or between a cell and a surface or extracellular matrix; and have applications in many areas of disease study, including neuroscience, cancers, and inflammation, among others.A strength of the p16-expression assay is certainly that it’s not particular for HPV type, unlike the in situ hybridization assays; therefore, p16-expression status is a very great surrogate for tumor HPV status. The superior prognosis for HPV-positive oropharyngeal squamous-cell carcinoma, in comparison with that for the HPV-negative cancer, seems to have multifactorial underpinnings. Known favorable prognostic elements associated with the HPV-positive subgroup take into account around 10 percent of the detected difference in result.